Earl Martin Douglas, General Counsel at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 3,500 shares at $15.20 ($53K) on 2008-01-23, disclosed to the SEC on 2008-01-24.
Open-market purchase of $53k BMTI by General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.19 | 300 | $5K | 8.5% |
| 2 | $15.20 | 200 | $3K | 5.7% |
| 3 | $15.26 | 100 | $2K | 2.9% |
| 4 | $15.30 | 2,900 | $44K | 82.9% |
| Total | $15.28 avg | 3,500 | $53K | 100% |
| Filing → |
| ALLO | SELL | 2025-02-05 | $11K | — | Filing → |
| BMTI | SELL | 2012-03-28 | $126K | — | Filing → |
| BMTI | SELL | 2011-10-14 | $27K | — | Filing → |